Boluwatife "Olu" Afolabi is a Nigerian clinician-scientist and doctoral researcher at the University of Minnesota, Twin Cities, specializing in oral and craniofacial sciences. His research focuses on the molecular mechanisms of head and neck squamous cell carcinoma (HNSCC), specifically investigating the role of the aryl hydrocarbon receptor (AHR) pathway and the suppression of the inflammatory protein calprotectin in cancer progression.
Afolabi began his medical career at the University of Ibadan’s College of Medicine, where he trained as a dental surgeon and conducted early research on dental radiation safety and cervicofacial necrotizing fasciitis. His clinical foundation informs his current work, which aims to bridge the gap between basic laboratory science and patient care in the field of oncology. He is currently a PhD candidate in Oral Biology at the University of Minnesota, working under the mentorship of Prof. Mark Herzberg and Dr. Chong Wang.
His scientific work utilizes advanced methodologies, including CRISPR-Cas9 gene editing, epigenetic analysis, and multi-omics data integration.
Boluwatife "Olu" Afolabi is a Nigerian clinician-scientist and doctoral researcher at the University of Minnesota, Twin Cities, specializing in oral and craniofacial sciences. His research focuses on the molecular mechanisms of head and neck squamous cell carcinoma (HNSCC), specifically investigating the role of the aryl hydrocarbon receptor (AHR) pathway and the suppression of the inflammatory protein calprotectin in cancer progression.
Afolabi began his medical career at the University of Ibadan’s College of Medicine, where he trained as a dental surgeon and conducted early research on dental radiation safety and cervicofacial necrotizing fasciitis. His clinical foundation informs his current work, which aims to bridge the gap between basic laboratory science and patient care in the field of oncology. He is currently a PhD candidate in Oral Biology at the University of Minnesota, working under the mentorship of Prof. Mark Herzberg and Dr. Chong Wang.
His scientific work utilizes advanced methodologies, including CRISPR-Cas9 gene editing, epigenetic analysis, and multi-omics data integration.